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The N-methyl-D-aspartate (NMDA) subtype of excita-
tory glutamate receptors plays critical roles in embry-
onic and adult synaptic plasticity in the central nervous
system. The receptor is a heteromultimer of core sub-
units, NR1, and one or more regulatory subunits,
NR2A-D. Protein phosphorylation can regulate NMDA
receptor function (Lieberman, D. N., and Mody, I. (1994)
Nature 369, 235–239; Wang, Y. T., and Salter, M. W. (1994)
Nature 369, 233–235; Wang, L.-Y., Orser, B. A., Brautigan,
D. L., and MacDonald, J. F. (1994) Nature 369, 230–232).
Here we identify a major phosphorylation site on sub-
unit NR2B that is phosphorylated by Ca21/calmodulin-
dependent protein kinase II (CaM kinase II), an abun-
dant protein kinase located at postsynaptic sites in
glutamatergic synapses. For the initial identification of
the site, we constructed a recombinant fusion protein
containing 334 amino acids of the C terminus of the
NR2B subunit and phosphorylated it with CaM kinase II
in vitro. By peptide mapping, automated sequencing,
and mass spectrometry, we identified the major site of
phosphorylation on the fusion protein as Ser-383, corre-
sponding to Ser-1303 of full-length NR2B. The Km for
phosphorylation of this site in the fusion protein was
;50 nM, much lower than that of other known substrates
for CaM kinase II, suggesting that the receptor is a high
affinity substrate. We show that serine 1303 in the full-
length NR2B and/or the cognate site in NR2A is a major
site of phosphorylation of the receptor both in the
postsynaptic density fraction and in living hippocampal
neurons.
Plasticity in the strength of transmission at synapses is
essential for higher order brain functions such as learning and
memory (1). In the hippocampus and cortex, activation of the
NMDA1 subtype of glutamate receptors can trigger long lasting
changes in synaptic strength. These changes include long term
potentiation (2) and long term depression (3). NMDA receptors
contain two classes of subunits in hetero-oligomeric associa-
tions, the core NR1 subunit and the regulatory NR2 (A–D)
subunits (4, 5). The NR2 subunits are equipped with uniquely
long carboxyl-terminal tails that are believed to extend into the
cytoplasm (6). These tails may participate in transduction
mechanisms or in forms of regulation of the NMDA receptor
that are not yet fully understood. NR2A and NR2B are the
major regulatory subunits of NMDA receptors in the forebrain
(4, 5). Previous work from this laboratory has shown that
NR2B is the principal NMDA receptor subunit found in the
postsynaptic density fraction prepared from forebrain (7), sug-
gesting that this subunit may participate in anchoring the
NMDA receptor at postsynaptic sites. Indeed, recent work from
our lab and the Seeburg lab (8) has demonstrated a direct
association between NR2B and the postsynaptic density
protein PSD-95.
NMDA receptors are ligand and voltage-gated Ca21 channels
(9, 10). Binding of glutamate released from the presynaptic
terminal, coupled with strong depolarization of the postsynap-
tic membrane produces an influx of Ca21 into the postsynaptic
compartment (11). This Ca21 influx initiates a wide array of
biochemical events in the synapse that can lead to long term
potentiation or long term depression (12, 13). One potential
target for immediate activation by this Ca21 influx is CaM
kinase II. CaM kinase II has long been known to be concen-
trated in the postsynaptic density (14–17) and to be essential
for expression of both long term potentiation and long term
depression (18–20). One target for regulation by CaM kinase II
at the postsynaptic site may be the a-amino-3-hydroxy-5-meth-
yl-4-isoxazolepropionic acid-type glutamate receptor subunit
GluR1 (21), although uncertainty about the topology of receptor
folding has cast some doubt on the significance of direct phos-
phorylation of GluR1 in vivo (22). Another potential target for
phosphorylation is the NMDA receptor itself. Indeed, electro-
physiological evidence indicates that NMDA receptor-mediated
currents can be enhanced by protein phosphorylation (23–26).
However, direct demonstration of the role of phosphorylation of
the receptor itself in regulating its function requires identifi-
cation of sites on the receptor subunits that are phosphorylated
by particular protein kinases. Sites of phosphorylation of NR1
by protein kinase C have been located in the alternatively
spliced C-terminal region, and their role in regulating receptor
function in vitro has been demonstrated (27). Here we report
the identification of a principal site of phosphorylation of the
NR2B subunit of the NMDA-type glutamate receptor by CaM
kinase II. We show that this site and/or its cognate site in
NR2A is phosphorylated both in vitro and in vivo.
EXPERIMENTAL PROCEDURES
Materials—Acetonitrile, UV/HPLC grade, was purchased from Bax-
ter; Optima/HPLC grade water from Fisher; HPLC/Spectra grade tri-
fluoroacetic acid from Pierce; dithiothreitol (DTT) from Boehringer
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Mannheim; iodoacetamide from Sigma; [g-32P]ATP from ICN Pharma-
ceuticals Inc.; modified sequencing grade trypsin from Promega; se-
quencing grade trypsin from Boehringer Mannheim; C18 reverse phase
HPLC columns (4.6 3 250 mm) from Vydac; cellulose-coated TLC sheets
(20 3 20 mm) from EM Science; glutathione-agarose from Sigma; pro-
tein A-agarose from Pierce; phosphate-free minimal essential medium
from Life Technologies, Inc.; and PhosphorImager screens and scanner
from Molecular Dynamics. Calmodulin was purified by the method of
Watterson et al. (28). CaM kinase II was purified from rat forebrain
(29). Rabbit and mouse antiserum against NR2B was raised by immu-
nization with GST-tNR2B as described previously (7). The rabbit anti-
serum against NR2B does not cross-react with the NR2A subunit (data
not shown). Inhibitory monoclonal antibodies against CaM kinase II
were raised and selected by the method of Ref. 30 after immunization of
mice with purified CaM kinase II.
Preparation of Postsynaptic Density Fraction from Rat Brain—The
crude PSD fraction was prepared as described previously (31) by a
modification of the method of Carlin et al. (49).
Expression and Purification of the Fusion Protein GST-tNR2B from
Escherichia coli—A vector for expression of a fusion protein containing
the C-terminal 334 residues of NR2B fused to the C terminus of gluta-
thione S-transferase (GST-tNR2B) was constructed in the pGEX3X
plasmid (Pharmacia Biotech Inc.; Ref. 32) as described previously (7). A
single colony of E. coli cells transformed with the plasmid was selected
on an LB plate containing ampicillin and was grown in cultures con-
taining 50 mg/ml ampicillin at 30 °C overnight. When 2-liter cultures
reached mid-log phase (A600 of 0.5 units), the cells were induced by
adding 0.1 mM isopropyl-thiogalactoside and grown to late log phase at
30 °C. Cells were harvested by centrifugation, and the cell pellets were
frozen at 280 °C. The cell pellet from a 2-liter culture was resuspended
in 20 ml of 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM
KH2PO4, pH 7.3. (phosphate-buffered saline) containing 0.02 mg/ml
aprotinin, 0.01 mg/ml leupeptin, 5 mg/ml antipain, 0.4 mg/ml pepstatin,
0.1 mM PMSF, 0.5 mM DTT, 1 mM EDTA, and 1 mM EGTA. Cells were
lysed by sonication. PMSF was added again to a concentration of 0.1
mM, and Triton X-100 was added to a concentration of 1%. The cell
lysate was subjected to centrifugation at 15,000 3 g for 10 min. The
supernatant was saved, and the pellet was resuspended in 10 ml of
phosphate-buffered saline containing 1% n-lauroyl sarcosine (33) and
0.1 mM PMSF. The pellet was sonicated, and Triton X-100 and PMSF
were added to concentrations of 1% and 0.1 mM, respectively. The
suspension was subjected to centrifugation at 15,000 3 g. This and
previous supernatants were pooled and incubated at room temperature
for 10 min with 2 ml of glutathione-agarose beads previously washed
twice with phosphate-buffered saline. The supernatant solution was
removed from the beads, and the beads were washed twice with phos-
phate-buffered saline. The beads were then mixed with elution buffer
containing 50 mM Tris, pH 8.0, 20 mM reduced glutathione, 1% Triton
X-100, and 0.1 mM PMSF overnight at 4 °C on an end-over-end mixer.
The eluate was removed from the beads and stored at 280 °C. Addi-
tional fusion protein could be recovered from the first bead supernatant
by a second round of affinity purification.
Phosphorylation of GST-tNR2B by CaM Kinase II—Phosphorylation
of the fusion protein was conducted as described previously (34). The
reaction (final volume 100 ml) contained 50 mM Tris-HCl, pH 8.0, 10 mM
MgCl2, 0.7 mM CaCl2, 0.4 mM EGTA, 30 mM [g-
32P]ATP (1500–3000
cpm/pmol), 10 mg/ml calmodulin, 10 mM DTT, GST-tNR2B, and 1.2
mg/ml rat brain CaM kinase II. Phosphorylation was initiated by the
addition of 10 ml of kinase solution in Tris buffer, pH 8.0, containing
0.5–1.0 mg/ml BSA, to the reaction mixture, which was prewarmed to
30 °C for 1 min. The reaction was carried out for 1 min or as indicated
and was stopped by the addition of either 50 ml of 3 3 SDS sample
buffer or 4 ml of 500 mM EDTA. When the reaction was stopped by the
addition of SDS, the mixture was placed in a boiling water bath for 5
min before SDS-PAGE.
Trypsinization of Phosphorylated GST-tNR2B—GST-tNR2B was
phosphorylated as described above with the following modifications.
The reaction was conducted in a volume of 1 ml containing 16 or 54
mg/ml GST-tNR2B. The reaction mix was preincubated for 5 min, and
the reaction was initiated by the addition of 1.2 mg of CaM kinase II.
After 15 min, another 1.5 mg of CaM kinase II (in 0.5 ml) was added, and
the reaction continued for 15 min at 30 °C. The reaction was stopped by
the addition of EDTA, pH 8.0, to a final concentration of 19 mM. Several
reactions were pooled into 6–8-ml batches and placed on ice. Protein
was precipitated by the addition of trichloroacetic acid to a final con-
centration of 16%. After 1 h on ice, protein was pelleted by centrifuga-
tion for 15 min at 12,000 3 g. The supernatants were discarded, and the
pellets were washed twice with acetone to remove traces of trichloro-
acetic acid. The pellets were then dried in air and redissolved in 100–
250 ml of carboxymethylation buffer containing 200 mM Tris-HCl, pH
8.0, 8 M urea, 2 mM EDTA, and 2 mM DTT. The tubes were flushed with
nitrogen to remove air and incubated at 50 °C for 30 min to reduce
cysteine residues. To carboxymethylate the cysteine residues, iodoacet-
amide, pH 8.0, was added to a final concentration of 4.5 mM, and the
tubes were then flushed with nitrogen and incubated at 50 °C for 1 h,
protected from light. 2-Mercaptoethanol was added to a final concen-
tration of 1% (v/v), and the tubes were incubated at 50 °C for 10 min to
quench excess iodoacetamide. The reaction mixtures were then diluted
to a final concentration of 2 M urea, and protein was precipitated by the
addition of a final concentration of 20% trichloroacetic acid. After 15
min on ice, protein was pelleted by centrifugation at 12,000 3 g for 10
min. Pellets were washed twice with acetone to remove traces of tri-
chloroacetic acid, air-dried for 10 min, redissolved in 1 3 SDS-sample
buffer, boiled for 5 min, and loaded onto an 8% SDS-polyacrylamide gel
(1.5 mm thick). The GST-tNR2B bands were visualized by staining with
Coomassie Blue. The bands were cut out of the gel and washed twice in
10 ml each of 50% methanol and 10% acetic acid for 3 h, 10 ml of 50%
methanol overnight, 10 ml of 20% isopropyl alcohol for 1 h, and again in
10 ml of 50% methanol for 30 min. The bands were then lyophilized to
dryness. Each band, containing about 50 mg of GST-tNR2B, was reswol-
len in 0.9 ml of 0.1 M NH4HCO3 and was homogenized using a mini
homogenizer and pestle (Kontes Scientific Glassware/Instruments).
Modified sequencing grade trypsin (25–30 mg in 1 mM DTT) was added
to each gel suspension, the final volume was brought to 1 ml, and the
tubes were incubated in a 37 °C shaker water bath for 24 h. After
trypsinization, each gel suspension was pelleted by brief centrifugation,
and the supernatant (;0.6 ml) containing peptides was transferred to a
fresh tube. The gel pellets were washed with 0.4 ml of 0.1 M NH4HCO3,
and the washes were added to the previous supernatants. An additional
5 mg of sequencing grade trypsin was added to each supernatant along
with fresh DTT to a final concentration of 1 mM, and the tubes were
incubated in a 37 °C shaker water bath for another 13 h. The superna-
tant was then lyophilized to dryness. To recover additional peptides, 1
ml of 0.1 M NH4HCO3, 1 mM DTT containing 6 mg of sequencing grade
trypsin was added to the gel pellets, and they were incubated at 37 °C
for another 13 h. Sequencing grade trypsin (3 mg) and 1 mM DTT were
added to the supernatants, and they were incubated at 37 °C for an
additional 8 h. The final supernatants were pooled with the lyophilized
peptides from the previous supernatants and again lyophilized to
dryness.
HPLC Fractionation of Phosphopeptides—Lyophilized peptides were
dissolved in 1 ml of 0.1% trifluoroacetic acid and fractionated in two
batches by HPLC on a C18 reverse phase column (4.1 3 250 mm). The
column was developed at 1 ml/min with a gradient of 0–42% acetoni-
trile. Absorbance at 214 nm was monitored, and 0.5-ml fractions were
collected. Radioactivity in each fraction was measured in a Beckman LS
7800 scintillation counter by detection of Cerenkov radiation (34).
Mass Spectrometry and Sequencing of Phosphopeptides—Mass spec-
trometry was conducted by the Protein/Peptide Micro Analytical Labo-
ratory at Caltech with a PerSeptive Biosystems/Vestec Lasertech II
reflector for matrix-assisted, laser desorption ionization, time-of-flight
mass spectrometry (MALDI-TOF). Concentrated peak fractions of pep-
tides were mixed with an a-cyano-4-hydroxycinnamic acid matrix solu-
tion, dried, and placed in the mass spectrometer. Data were collected in
both linear and reflector modes.
Amino acid sequencing was performed in the Protein/Peptide Micro-
Analytical Laboratory with a Perkin-Elmer/Applied Biosystems Inc.
model 476A automatic protein sequenator.
Immunoprecipitation of NR2B from the Postsynaptic Density Frac-
tion—The postsynaptic density fraction was phosphorylated by endog-
enous CaM kinase II in the assay solution described above without the
addition of exogenous kinase. For Fig. 1, the reaction was carried out
with [g-32P]ATP (4500 cpm/pmol) for 2 min. For generation of tryptic
peptides, the reaction was carried out with [g-32P]ATP (60,000 cpm/
pmol) for 2 min. The reaction was stopped by the addition of a final
concentration of 0.2% SDS and boiled for 3 min. Immunoprecipitation
was carried out by the addition of RIPA buffer (10 mM Tris, pH 7.4, 1
mM EDTA, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate)
and rabbit antiserum against NR2B (final dilution 1:20 in a volume of
0.2 or 0.8 ml). The final SDS concentration was 0.1%. The antibody
solutions were mixed in the cold room for 2–12 h, cleared by centrifu-
gation at 12,000 3 g for 15 min, mixed with protein A-agarose beads
previously washed with 1 3 RIPA buffer, and stirred again for 2 h in the
cold room. The protein A beads were then pelleted and washed three
times with 2 volumes of 1 3 RIPA buffer. SDS sample buffer (50–100
ml/200 ml of protein A beads) was added to the beads. The mixture was
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boiled for 5 min and subjected to SDS-PAGE on a 6% gel. The NR2B
bands were visualized by either Coomassie staining or autoradiogra-
phy. The NR2B bands were excised and were subjected to tryptic
peptide mapping as for GST-tNR2B except that the carboxymethylation
was omitted.
Detection of the Phosphorylated Site on the NR2 Subunits with a
Phosphosite-specific Antibody—A synthetic peptide with the sequence
LRRQHSYDTFVC was obtained from the Peptide Sequencing Facility
at Caltech. Ten mg was phosphorylated for 2 h at 30 °C in 44 mM
Tris-HCl, pH 8, 9 mM MgCl2, 0.35 mM EGTA, 0.6 mM CaCl2, 0.26 mg/ml
calmodulin, 2.2 mM DTT, 13.2 mM [g-35S]thiophospho-ATP (1000 cpm/
nmol), 0.53 mg/ml CaM kinase II in a final volume of 0.85 ml. The
solution was brought to 0.4% trifluoroacetic acid, and the phosphopep-
tide was purified by HPLC and conjugated via succinimidyl 4-(N-male-
imidomethyl)cyclohexane-1-carboxylate to keyhole limpet hemocyanin.
Rabbit antisera were raised as described previously (7) by repeated
injection of 0.33 mg of conjugated peptide in RIBI adjuvant (RIBI
Immunochemical Research Inc., Hamilton, MT) at several sites. Serum
was collected and tested on immunoblots as described below against 0.2
mg of phosphorylated and 0.2 mg of nonphosphorylated GST-tNR2B.
The serum of one rabbit showed good specificity for phospho-GST-
tNR2B. To neutralize antibodies against nonphosphorylated GST-
tNR2B, the serum was preabsorbed with 6 mol eq of the nonphospho-
rylated antigen peptide at 4 °C overnight before dilution for use on
immunoblots.
Nonphosphorylated and phosphorylated rat brain homogenates were
prepared as follows. A rat brain was homogenized in 14 ml of homoge-
nization buffer containing 20 mM Tris-HCl, pH 8.0, 1 mM imidazole, 2
mM EDTA, 2 mM EGTA, 25 mg/liter soybean trypsin inhibitor, 1 mg/
liter leupeptin, 2 mM DTT, 0.1 mM PMSF with eight strokes in a
Teflon/glass homogenizer rotated at 900 rpm. The homogenate was
cleared by centrifugation at 2000 3 g for 10 min. Two ml of homogenate
was incubated for 1 h at 30 °C to permit dephosphorylation of proteins
by endogenous phosphatases. One ml was then removed and brought to
3% SDS, 5% glycerol, 2% b-mercaptoethanol, and 62 mM Tris-HCl, pH
6.7 (SDS-PAGE sample buffer). The other ml of dephosphorylated ho-
mogenate was added to an equal volume of prewarmed phosphorylation
mixture containing (final volume) 50 mM Tris, pH 7.5, 0.7 mM CaCl, 0.3
mM EGTA, 10 mM MgCl, 5 mg/ml calmodulin, 10 mM ATP, 10 mM DTT,
0.06 mg/ml CaM kinase II, and 1 mM okadaic acid to inhibit protein
phosphatases. The mixture was incubated for 5 min at 30 °C and then
brought to 3% SDS, 5% glycerol, 2% b-mercaptoethanol, and 62 mM
Tris-HCl, pH 6.7. Aliquots of both the nonphosphorylated and the
phosphorylated homogenates were boiled for 2 min and stored at
280 °C for later application to SDS-PAGE gels.
Homogenates of hippocampal slices were prepared as described pre-
viously (35). Briefly, hippocampi were dissected from rat brains and
placed in ice-cold, oxygenated Ringer buffer (119 mM NaCl, 2.5 mM KCl,
1.3 mM MgSO4, 2.5 mM CaCl2, 1 mM NaH2PO4, 26.2 mM NaHCO3, 11
mM glucose). Slices (500 mm) were cut with a tissue chopper (Stolting,
Wood Dale, Il), placed on filter paper on top of a Petri dish containing
oxygenated, ice-cold Ringer buffer, and incubated at room temperature
in a chamber flushed continuously with 95% O2, 5% CO2. After 1 h,
groups of 12 slices were immersed in oxygenated Ringer buffer or in the
same buffer containing either 5 mM okadaic acid or 0 CaCl2/0.25 mM
EGTA, for an additional hour at room temperature in a 95% O2, 5% CO2
atmosphere. The slices were then immediately transferred to a Teflon/
glass homogenizer containing 600 ml of SDS-PAGE sample buffer plus
2 units of DNase and homogenized. Each homogenate was boiled for 5
min and frozen for later application to SDS-PAGE gels.
For detection of the phosphorylated site in homogenates, 25–40 mg of
homogenate protein/lane was fractionated by SDS-PAGE, electro-
phoretically transferred to nitrocellulose, and blocked for 5 h in 5% dry
milk (Carnation) diluted in TTBS (0.05% Tween-20, 20 mM Tris-Cl, pH
7.5, 0.5 M NaCl). After one wash in TTBS, blots were incubated over-
night in anti-phosphosite-specific rabbit serum preabsorbed with non-
phosphoantigen as described above and then diluted 1:2000 in TTBS
plus 1% normal goat serum. Blots were washed three times in TTBS,
then incubated for 1 h in alkaline phosphatase-conjugated goat anti-
rabbit secondary antibodies (Jackson Immunochemicals) diluted in
TTBS plus 1% normal goat serum. After three 10-min washes with
TTBS, blots were developed with nitro blue tetrazolium/5-bromo-4-
chloro-3-indolyl phosphate color reagent (Bio-Rad) according to the
supplier’s instructions.
Immunoprecipitation of NR2B from Hippocampal Slices—Organo-
typic hippocampal cultures were prepared and maintained for 4–6
weeks as described previously (36). Ten wells containing 4 or 5 cultures/
well were washed with minimal essential medium containing 100 mM
Na2HPO4, prewarmed to 37 °C. Then 1 ml of the same medium con-
taining 0.8 mCi of carrier free 32P-phosphate was added to each well.
The plates were transferred to a 37 °C CO2 incubator for 8 h. At the end
of the incubation, the labeling medium was aspirated off. The slices
were washed twice with Ringer buffer (125 mM NaCl, 2 mM KCl, 1.25
mM NaH2PO4, 2 mM MgSO4, 2 mM CaCl2, 26 mM NaHCO3, 10 mM
glucose, and 25 mM HEPES, pH 7.4), frozen on dry ice on glass slides,
and transferred to a 270 °C freezer overnight. The slices were thawed
on ice and homogenized in 1 ml of homogenization buffer (20 mM
Tris-HCl, pH 8.0, 1 mM imidazole, 2 mM EDTA, 20 mM sodium pyro-
phosphate, 25 mg/liter soybean trypsin inhibitor, 1 mg/liter leupeptin, 2
mM DTT, 0.1 mM PMSF, 2 mM EGTA) at 900 rpm with eight strokes.
The homogenate was brought to 0.2% SDS, placed in a boiling water
bath for 3 min, cooled in ice, and brought to 1 3 RIPA buffer, 0.1% SDS
(final volume 2 ml). The sample was cleared by centrifugation at
16,000 3 g for 5 min and then mixed with 100 ml of antiserum against
NR2B in the cold room for 2 h. Protein A-Sepharose beads (2-ml sus-
pension), washed once with RIPA buffer were added, and the incubation
continued for 2 h in the cold room with mixing. The protein A beads
were then pelleted by centrifugation and washed three times with 1 ml
of RIPA buffer. SDS sample buffer (0.25–0.5 ml) was added to the
washed beads and boiled for 5 min, and the mixture was subjected to
SDS-PAGE on a 6% gel. The NR2B bands were visualized by autora-
diography after drying the gel, excised, and subjected to tryptic diges-
tion as described above for GST-tNR2B.
Lyophilized tryptic peptides were dissolved in 0.1% trifluoroacetic
acid in 50% acetonitrile, spotted onto 20 3 20-cm cellulose-coated thin
layer plates, and fractionated in two dimensions (37). Electrophoresis in
the first dimension was at 600 V for 4 h, in a pH 3.5 buffer containing
5% acetic acid and 0.5% pyridine. The plates were dried and subjected
to thin layer chromatography in the second dimension in a solvent
containing n-butanol, pyridine, acetic acid, and water in the ratio 37.5:
25:7.5:30. Phosphopeptides were visualized by PhosphorImager analy-
sis (Molecular Dynamics).
Phosphoamino Acid Analysis—Organotypic hippocampal cultures
were prepared and washed as described above and then incubated in
minimal essential medium containing 100 mM NaH2PO4 and 1 mCi of
[g-32P]H3PO4 for 16 h at 37 °C. The slices were then washed twice with
Ringer buffer and homogenized in 600 ml of homogenization buffer with
eight strokes at 900 rpm. Nonidet P-40 and Triton X-100 were added to
the homogenate to final concentrations of 1 and 0.1%, respectively. The
homogenate was mixed end-over-end for 2 h at 4 °C. The homogenate
was then cleared by centrifugation at 12,000 3 g at 4 °C for 15 min. The
supernatant was transferred to a new tube, and 20 ml of a polyclonal
mouse antiserum against NR2B was added (7). The solution was mixed
end-over-end at 4 °C overnight and then subjected to centrifugation at
12,000 3 g at 4 °C for 15 min. The supernatant was transferred to a
tube containing 50 ml of protein A-agarose beads previously washed
with RIPA buffer and mixed end-over-end at 4 °C for 1 h. The beads
were pelleted by centrifugation at 12,000 3 g for 5 min and then washed
three times with RIPA buffer and resuspended in 30 ml of SDS stop
solution. Ten ml of the sample was loaded onto a 6% SDS-polyacryl-
amide gel. The gel was stained with Coomassie Blue and dried. Radio-
active NR2B was visualized by autoradiography. Gel bands were ex-
cised from the gel and placed in 1 ml of 30% methanol for 1 h, washed
twice in 50 mM NH4HCO3, and then incubated in the same solution
containing 20 mg of L-1-tosylamido-2-phenylethyl chloromethyl ketone-
treated trypsin overnight at 37 °C. The solution was removed from the
gel piece, dried under vacuum in a Speed-Vac centrifuge, resuspended
in 100 ml of 6 N HCl, and incubated at 110 °C for 1 h. The hydrolyzed
sample was dried in the Speed-Vac, redissolved in deionized water, and
dried again. It was then resuspended in 8 ml of deionized water con-
taining phosphoamino acid standards (2 mg each of phosphoserine,
phosphothreonine, and phosphotyrosine), and spotted onto a cellulose-
coated thin-layer chromatography plate. The plate was subjected to
electrophoresis as described previously (37) at 500 V for 2 h. The plate
was dried and sprayed with 0.25% ninhydrin in acetone to visualize the
standard amino acids. Radioactive amino acids were visualized by
PhosphorImager analysis (Molecular Dynamics)
Other Methods—SDS-PAGE was performed as described in Ref. 38
on 6, 8, or 10% SDS running gels. Stacking gels contained 3.5% acryl-
amide. Protein concentration was measured by the method of Peterson
(39) with bovine serum albumin as the standard. To estimate the
proportion of intact GST-tNR2B fusion protein (Mr ;63,000) in our
purified preparations (Fig. 2), Coomassie-stained bands containing in-
tact GST-tNR2B were visually compared with those of known amounts
of standard proteins. Because we estimated that intact GST-tNR2B was
about 30% of the total protein in the purified GST-tNR2B solution, the
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concentration of GST-tNR2B was taken as 30% of the total protein in
the sample determined by the method of Peterson.
RESULTS
Phosphorylation of NR2B by CaM Kinase II in the Postsyn-
aptic Density Fraction—To test whether NR2B is a substrate
for endogenous CaM kinase II in the PSD fraction, proteins in
the fraction were radiolabeled by phosphorylation with CaM
kinase II, as described under “Experimental Procedures,” and
then NR2B was immunoprecipitated from the radiolabeled
PSD fraction. Incorporation of phosphate into NR2B was rapid
and substantial, reaching a maximum of approximately 1 mol
of phosphate/mol of NR2B in 2 min, assuming that NR2B is
0.5% of total PSD protein (7). Furthermore, the phosphoryla-
tion was stimulated by Ca21 and was inhibited by monoclonal
antibodies raised against CaM kinase II (Fig. 1; Ref. 40).
Phosphorylation of GST-tNR2B by CaM Kinase II—Because
the amount of NR2B in the PSD fraction is less than 1% of total
protein (7), we anticipated that isolation of sufficient quantities
of phosphopeptide for automated sequencing of the endogenous
site would be difficult. Therefore, we tested whether a recom-
binant fusion protein containing just the carboxyl terminus of
NR2B could be phosphorylated by CaM kinase II. We con-
structed a pGEX plasmid in which cDNA encoding the C-
terminal 334 amino acids of NR2B was fused to DNA encoding
glutathione S-transferase. Fusion protein expressed in E. coli
cells was purified by solubilization in 1% N-lauroyl sarcosine
followed by affinity chromatography on a glutathione-agarose
column (see “Experimental Procedures”; Fig. 2A). Purified
GST-tNR2B was phosphorylated by CaM kinase II in vitro (Fig.
2B). As expected, the phosphorylation was dependent on the
presence of Ca21 and calmodulin. Recombinant glutathione
S-transferase alone was not phosphorylated by CaM kinase II,
indicating that phosphorylation of GST-tNR2B was likely oc-
curring on the C-terminal NR2B portion of the fusion protein
(data not shown). The phosphorylation was rapid and stoichi-
ometric (Fig. 3A). The Km for the fusion protein, calculated
from double reciprocal plots, was unusually low, 47.2 6 27.6 nM
(Fig. 3B), suggesting that CaM kinase II has a very high affin-
ity for the phosphorylation site(s) contained in the fusion
protein.
Purification of Tryptic Phosphopeptides from Phosphorylated
GST-tNR2B—To identify the phosphorylated site, 0.3 and 0.4
mg of fusion protein were exhaustively phosphorylated (in two
separate experiments) by CaM kinase II. Tryptic peptides were
generated from the phosphorylated protein and fractionated by
HPLC on a C18 reverse phase column as described under
“Experimental Procedures.” Seven major peaks of radioactivity
appeared reproducibly (Fig. 4, peaks 2–8). Peaks 5 and 6 and
peaks 7 and 8 always eluted as doublets migrating very closely
on the column. The phosphopeptides in peaks 5–8 were pure
enough for identification by mass spectrometry and/or auto-
mated sequencing. Peaks 2–4 contained multiple peptides re-
vealed by mass spectrometry, none of which could be positively
identified as a phosphopeptide (see below).
Determination of Molecular Masses of the Tryptic Peptides of
Phosphorylated GST-tNR2B by Mass Spectrometry—Peaks
5–8 from two separate fractionations were concentrated and
subjected to MALDI-TOF mass spectrometry in both the linear
and reflector modes (41). In reflector mode, fragmentation of
the phosphoryl group on phosphopeptides usually produces a
new parent peptide peak with a mass 97 atomic mass units less
than that of the phosphopeptide itself (41). Each of the four
samples showed a second peak in reflector mode with a mass 97
atomic mass units less than that of the major peak observed in
both linear and reflector mode (Fig. 5). The masses of the
dephospho forms of peaks 5, 6, 7, and 8 were 1619, 1446, 2456,
FIG. 1. Phosphorylation of NR2B by endogenous CaM kinase II
in the PSD fraction. Aliquots of the PSD fraction (50 mg) were incu-
bated in the assay mixture for CaM kinase II as described under
“Experimental Procedures.” Radiolabeled NR2B was immunoprecipi-
tated from each tube, and the pellets were fractionated by SDS-PAGE.
The figure shows an autoradiogram of the dried gel. Lane 1, incubation
without Ca21; lane 2, incubation with Ca21; lane 3, incubation with
Ca21 and inhibiting monoclonal antibodies 4A11 (28 mg) and 6E9 (20
mg); lane 4, incubation with Ca21 and 50 mg of nonimmune mouse IgG.
FIG. 2. Characterization of the GST-tNR2B fusion protein. A,
the fusion protein GST-tNR2B was expressed from an engineered cDNA
as described under “Experimental Procedures.” Aliquots of bacterial
lysates were fractionated on a 10% SDS gel, and proteins were visual-
ized by staining with Coomassie Blue. Lane 1, uninduced bacteria
containing the GST-tNR2B expression vector; lane 2, bacteria contain-
ing the expression vector after induction for 5 h with 0.1 mM isopropyl-
1-thio-b-D-galactopyranoside; lane 3, purified GST-tNR2B (3.7 mg; 6%
gel). Arrows point to the 63-kDa fusion protein. B, GST-tNR2B (1 mg)
was phosphorylated by CaM kinase II under three different conditions
in the presence of radiolabeled ATP as described under “Experimental
Procedures.” Each reaction mixture was fractionated on a 10% SDS-gel.
The figure shows an autoradiogram of the dried gel. Lane 1, complete
incubation with Ca21, calmodulin, and CaM kinase II; lane 2, incuba-
tion without Ca21 and calmodulin; lane 3, incubation without CaM
kinase II.
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and 2283, respectively. We also noted that the major peaks
present in samples 5 and 6 and in samples 7 and 8 differed in
molecular mass by approximately 174 atomic mass units, the
molecular mass of an arginine residue.
Sequencing of the Tryptic Peptides of Phosphorylated GST-
tNR2B—The peptides in fractions 5 and 7 were sequenced with
an automated gas phase sequencer (Table I). The sequences
revealed that these two peptides contain the same phosphoryl-
ated site, serine 383 in GST-tNR2B, which corresponds to
serine 1303 in full-length NR2B. The peptide present in frac-
tion 7 is eight residues longer than the peptide in fraction 5
because of an uncleaved tryptic site at lysine 392 (Table I). The
masses calculated from the sequences in Table I correspond to
those determined by mass spectrometry (Fig. 5), confirming the
identities of the phosphopeptides. Analysis of the phenylthio-
hydantoin-derivatives produced from both peptides during the
sequencing showed anomalously high yields of dehydroalanine
compared with that of serine in the fourth sequencing cycle,
which corresponds to serine 383. An anomalous high yield of
dehydroalanine has been shown to be a reliable indicator of the
presence of phosphoserine in a sequence (42). Serine 383/1303
is contained within a consensus sequence for phosphorylation
by CaM kinase II, having an arginine at position 23 (43).
When we attempted to sequence the phosphopeptide con-
tained in peak 6, we obtained two distinct sequences, neither of
which corresponded in mass to the phosphopeptide observed by
mass spectrometry. We thus concluded that this phosphopep-
tide has a blocked N terminus. The molecular masses of the
phosphopeptide (1544 atomic mass units) and the parent pep-
tide (1446 atomic mass units) from fraction 6 (Fig. 5) are those
expected for a limit tryptic peptide corresponding to peptide 5
with the N-terminal arginine (173 atomic mass units) removed.
The predicted limit peptide would have an N-terminal gluta-
mine residue, which rapidly cyclizes to form pyroglutamate and
is refractory to Edman degradation (44). We have previously
observed the formation of a phosphopeptide with a blocked N
terminus during the purification of peptides containing the
principal autophosphorylation site of CaM kinase II, which
contains a glutamine residue at position 22, just carboxyl to
the requisite arginine at position 23 (34). Based upon the
results of the mass spectrometry analysis, we conclude that the
phosphopeptide in peak 6 is identical to that in peak 5 without
the N-terminal arginine.
Peak 8 contained several peptides that were visible in the
mass spectrometer and was judged too impure for sequencing.
This peak appeared slightly behind peak 7 during reverse
phase HPLC (Fig. 4) and contained a single phosphopeptide
with a mass 173 atomic mass units less than the phosphopep-
tide present in peak 7 (Fig. 5). No other predicted tryptic
phosphopeptide from the fusion protein has a molecular mass
near 2382. Hence, we conclude that peak 8 contains a phos-
phopeptide with the same sequence as that in peak 7 with its
N-terminal arginine removed (Table I). Thus, phosphopeptides
5–8 represent the same phosphorylation site, serine 383 of the
fusion protein, corresponding to serine 1303 of the full-length
NR2B subunit (6, 45).
Serine 383 Is the Principal Site Phosphorylated Rapidly on
GST-tNR2B by CaM Kinase II—To study the rates of phospho-
rylation of GST-tNR2B at the sites observed after tryptic di-
gestion (Fig. 4), phosphorylation was carried out for various
times up to 10 min, and the amount of phosphate incorporated
into each tryptic phosphopeptide was determined after HPLC.
The amounts of phosphate incorporated into peaks 5–8 were
added together, and the sum was plotted and compared with
the incorporation of phosphate into other principal peaks (3
and 4) containing unidentified phosphopeptides (Fig. 6). The
FIG. 3. Kinetics of phosphorylation of GST-tNR2B by CaM ki-
nase II. A, GST-tNR2B (1 mg in 100 ml) was phosphorylated by CaM
kinase II for the indicated times as described under “Experimental
Procedures.” Phosphate incorporated into the fusion protein was meas-
ured after fractionation of the mixture by SDS-PAGE. B, GST-tNR2B at
the indicated concentrations was phosphorylated for 1 min as described
under “Experimental Procedures.” Phosphate incorporated into the fu-
sion protein was measured after fractionation of the mixture by SDS-
PAGE. The inset shows a Lineweaver-Burke double-reciprocal plot of
the data from this experiment. The Km values determined in three such
experiments were 37, 27, and 79 nM. For these calculations, the con-
centration of full-length GST-tNR2B was determined as described un-
der “Experimental Procedures.”
FIG. 4. Tryptic peptides generated from exhaustively phos-
phorylated GST-tNR2B. GST-tNR2B (0.4 mg) was phosphorylated for
30 min as described under “Experimental Procedures.” Tryptic frag-
ments were generated, and half of the reaction was fractionated on a
C18 reverse phase HPLC column as described under “Experimental
Procedures.” Radioactivity in each 0.5-ml fraction was measured by
detection of Cerenkov radiation. M, radioactivity; l, acetonitrile
concentration.
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most rapid phosphorylation occurs on serine 383, whereas in-
corporation of phosphate into peaks 3 and 4 is considerably
slower and reaches only ;10% of that into serine 383 after 10
min. (Recall that exhaustive phosphorylation of GST-tNR2B
prior to sequencing of the phosphopeptides (Fig. 4) was carried
out for 30 min.) Hence, serine 383 appears to be the preferred
site on GST-tNR2B for phosphorylation by CaM kinase II.
Serine 1303 in the NR2B Subunit Is Phosphorylated by En-
dogenous CaM Kinase II in the Postsynaptic Density Frac-
tion—To see whether Ser-1303 can be phosphorylated by CaM
kinase II in the full-length NR2B subunit, the rat brain
postsynaptic density fraction was incubated in the CaM kinase
II assay mixture described under “Experimental Procedures” to
allow endogenous kinase to catalyze phosphorylation of sub-
strate proteins. The NR2B subunit was then immunoprecipi-
tated from the mixture and fractionated by SDS-PAGE (see
Fig. 1). The protein band was excised from the gel, and the
labeled NR2B subunit was subjected to tryptic peptide map-
ping. The major peaks of radioactivity corresponded in mobility
to peaks 7 and 8 from phosphorylated GST-tNR2B (Fig. 7, top
and middle), and a smaller peak corresponding to peak 5 was
also present. The identities of the peaks were confirmed by
chromatography of mixtures of tryptic peptides generated from
phosphorylated NR2B and those generated from phosphoryl-
ated GST-tNR2B (Fig. 7, bottom). Thus, serine 1303 is a major
target for phosphorylation by CaM kinase II in the full-length
NR2B subunit. The presence of additional minor peaks in the
NR2B digest (Fig. 7, top) indicates that a site (or sites) not
present in GST-tNR2B may also be phosphorylated by CaM
kinase II.
Serine 1303 in the NR2B Subunit Is Phosphorylated by CaM
Kinase II in the Hippocampus—A rabbit antiserum specific for
the amino acid sequence surrounding phosphorylated serine
1303 was raised by immunizing rabbits with a phosphopeptide
(Fig. 8A). When preabsorbed with the cognate nonphosphopep-
tide, this antiserum specifically recognizes a band at the posi-
tion of NR2B in immunoblots of brain homogenates subjected
to phosphorylation conditions in vitro (Fig. 8B, first two lanes).
We have previously shown that in acutely prepared slices of rat
hippocampus, the basal level of active, autophosphorylated
FIG. 5.Mass spectra of the purified tryptic peptides. Peptides in
the indicated peaks (numbered as in Fig. 4) were subjected to MALDI-
TOF mass spectrometry in linear and reflector modes as described
under “Experimental Procedures.” The masses in atomic mass units for
each phosphopeptide and its parent dephosphoryl form, measured after
external calibration, are indicated above the peaks. The x axis (m/z)
represents the ratio of mass to charge, and the y axis represents arbi-
trary units related to the size of the signal.
TABLE I
Sequences of purified peptides from peaks 5–8
Sequences were determined by automated sequencing and/or
MALDI-TOFmass spectrometry as described under “Experimental Pro-
cedures.” The phosphoserine residue corresponding to Ser-383 of GST-
tNR2B is marked with an asterisk. The sequences were determined
from two different preparations of peaks 5–8.
Peak Sequence
5 R Q H S* Y D T F V D L Q K
6 Q H S* Y D T F V D L Q K
7 R Q H S* Y D T F V D L Q K E E A A L A P R
8 Q H S* Y D T F V D L Q K E E A A L A P R
FIG. 6. Rates of phosphorylation by CaM kinase II of different
sites in GST-tNR2B. GST-tNR2B (25 mg) was phosphorylated in the
presence of CaM kinase II and labeled ATP for the indicated times, after
which the phosphorylated GST-tNR2B was trypsinized as described
under “Experimental Procedures” and the tryptic peptides were frac-
tionated by HPLC. The sum of the radioactivity in peaks 5–8 (equal to
incorporation of phosphate into serine 383), and the radioactivity in
individual peaks 3 and 4, were plotted at each time point. f, sum of
radioactivity in peaks 5–8 (ser-383); l, radioactivity in peak 3; ,
radioactivity in peak 4.
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CaM kinase II can be manipulated by incubating the slices in a
ringer buffer containing EGTA, which lowers the level of active
kinase from an average of 9% (40) to about 4%, or in okadaic
acid, which raises the level of active kinase to about 27% (34).
To determine if serine 1303 is phosphorylated in intact hip-
pocampal neurons under any of these conditions, we prepared
homogenates of slices incubated in normal Ringer buffer and in
Ringer buffer containing EGTA or okadaic acid, as described
under “Experimental Procedures.” We were able to clearly de-
tect the presence of the phosphorylated site in a protein band at
the position of NR2B in homogenates of slices incubated under
each condition (Fig. 8B). The band detected by the antisera is
darker in homogenates of slices incubated in okadaic acid,
consistent with phosphorylation by CaM kinase II, which is
more highly active in slices under that condition.
Six amino acids of the 12-residue peptide antigen used to
raise the anti-phosphosite antibody are conserved in both the
NR2A and NR2B subunits of the NMDA receptor (6). These two
subunits have similar molecular weights and co-migrate on
SDS-PAGE (data not shown). For this reason, it is possible that
the phosphosite-specific antibody used for the experiments in
Fig. 8 recognizes both NR2A and NR2B. We performed addi-
tional experiments in which radiolabeled NR2B was immuno-
precipitated from homogenates of labeled organotypic hip-
pocampal cultures with antibody specific for NR2B (Figs. 9 and
10). For identification of labeled phosphoamino acids, precipi-
tated NR2B was subjected to SDS-PAGE, and the labeled pro-
tein band was excised from the gel and hydrolyzed as described
under “Experimental Procedures.” The acid hydrolysate was
fractionated by electrophoresis on a cellulose thin layer plate,
and radioactive amino acids were visualized in a PhosphorIm-
ager. A single radioactive spot was detected that co-migrated
with the phosphoserine standard (Fig. 9), indicating that the
major sites of phosphorylation of NR2B in vivo under these
conditions are serine residues.
In a separate experiment, the labeled NR2B was trypsinized
as described under “Experimental Procedures.” Because their
specific activity was too low for detection in fractions from
HPLC, the peptides were fractionated by two-dimensional thin
layer chromatography (Fig. 10A). On separate plates, the di-
gest was mixed with phosphopeptides 5, 7, and 8 purified by
HPLC after trypsinization of radiolabeled GST-tNR2B (Fig.
10C; see also Fig. 4). We found that NR2B was phosphorylated
in vivo in the cultures and that its trypsinization gave rise to
two phosphopeptides with mobilities similar to peptides 7 and
8 (Fig. 10, A–C). The two sets of peptides co-migrate when
mixed before application to the plate, confirming their identi-
ties (Fig. 10C). This evidence indicates that NR2B itself can be
phosphorylated on serine 1303 in vivo. In these experiments, as
in those shown in Fig. 7, the presence of additional phos-
phopeptides in the digests of intact NR2B suggests that it may
also be phosphorylated on sites not present in GST-tNR2B. The
additional peptides labeled in vivo could also reflect phospho-
rylation anywhere in NR2B by kinases other than CaM kinase
II.
DISCUSSION
We have found that phosphorylation of the NR2B subunit of
the NMDA receptor is stimulated in the PSD fraction from rat
FIG. 7. Serine 1303 in NR2B is phosphorylated by endogenous
CaM kinase II in the PSD fraction. An aliquot of the PSD fraction
from forebrain (400 mg) was phosphorylated for 2 min in the presence of
CaM kinase II and labeled ATP. Phosphorylated NR2B was immuno-
precipitated as described under “Experimental Procedures.” In a par-
allel reaction, GST-tNR2B (25 mg) was phosphorylated for 2 min. The
immunoprecipitated NR2B and GST-tNR2B were purified by SDS-
PAGE and digested with trypsin in parallel reactions. The tryptic
peptides were subjected to HPLC on a C18 reverse phase column.
Radiolabeled tryptic peptides are shown from phosphorylated NR2B
from the equivalent of 300 mg of PSD fraction (top), phosphorylated
GST-tNR2B (8 mg) (middle), and phosphorylated NR2B and GST-
tNR2Bmixed before application to the column (bottom). The left column
shows the entire HPLC profile; the right column shows an expanded
view of the fractions containing peptides 7 and 8.
FIG. 8. Detection of phosphorylation of serine 1303 in acute
hippocampal slices with a phosphosite-specific antiserum. A, a
rabbit antiserum was raised against a 12-residue phosphopeptide mim-
icking the sequence surrounding phosphorylated serine 1303 in NR2B,
as described under “Experimental Procedures.” The serum was preab-
sorbed with a molar excess of the cognate nonphosphopeptide and was
used to probe an immunoblot containing 0.2 mg of phospho- (P) or
nonphospho- (NP) GST-tNR2B. The arrow shows the position of GST-
tNR2B. The lower Mr bands are partial products formed during bacte-
rial expression (see Fig. 2). B, aliquots of homogenates of rat forebrain
were subjected to dephosphorylating conditions (FBH-NP), or to de-
phosphorylating conditions followed by phosphorylation by CaM KII
(FBH-P) as described under “Experimental Procedures.” Each homoge-
nate (25 mg) was fractionated by SDS-PAGE and probed on immuno-
blots with a 1:2000 dilution of phosphosite-specific antiserum as de-
scribed under “Experimental Procedures.” C, three sets of 12 acute
hippocampal slices were prepared and incubated in an oxygenated
chamber for 1 h and then switched to oxygenated Ringer buffer con-
taining 0 Ca21, 0.25 mM EGTA (EGTA), no additions (No Tr.), or 5 mM
okadaic acid (Ok. Acid) (see “Experimental Procedures”). After 1 h of
incubation in an oxygenated chamber, the sets of slices were homoge-
nized immediately in SDS-PAGE sample buffer and boiled for 3 min.
The first three lanes are immunoblots of 25 mg of each of the three
homogenates with the phosphosite-specific antiserum diluted 1:2000.
These lanes were contained in the same blot as those shown in B. The
last two lanes are similar immunoblots of 40 mg of the EGTA and
okadaic acid-treated homogenates. Arrows, the position of NR2B in B
and C. It was determined by immunostaining an adjacent lane of
homogenate with antiserum against NR2B.
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brain by the addition of Ca21. The Ca21-stimulated phospho-
rylation is inhibited by antibodies that specifically inhibit the
activity of CaM kinase II (Fig. 1; Ref. 40). To facilitate identi-
fication of the site(s) of phosphorylation on NR2B by CaM
kinase II we have used a recombinant fusion protein containing
the C-terminal 334 amino acid residues of the NR2B subunit
fused to the C terminus of glutathione S-transferase. The fu-
sion protein (GST-tNR2B) was purified in 9-mg quantities and
served as a substrate in vitro for purified CaM kinase II (Fig.
2). GST-tNR2B could be phosphorylated in 10 min to a stoichi-
ometry of 1.4 mol/mol of protein (Fig. 3A). All of the phospho-
rylation occurred on the NR2B portion of the fusion protein.
The Km for phosphorylation of GST-tNR2B was approximately
50 nM (Fig. 3B), indicating that the affinity of the kinase for the
site on GST-tNR2B is considerably higher than for other
known protein substrates. For example, the Km for phospho-
rylation of synapsin I by CaM kinase II is 0.4 mM (46); for a
peptide containing the amino-terminal 10 residues of glycogen
synthase it is 7.5 mM, and for a peptide containing the amino-
terminal 23 residues of smooth muscle myosin light chain it is
4 mM (43). The high affinity of the kinase for GST-tNR2B is
corroborated by the observation that the fusion protein inhibits
completely the phosphorylation of synapsin I when the two are
present at the same concentration in the assay (data not
shown).
Four of the seven major tryptic phosphopeptides (numbered
5–8 in Fig. 4) generated after exhaustive phosphorylation of
GST-tNR2B were identified by mass spectrometry and gas
phase sequencing as originating from serine 383 of the NR2B
portion of GST-tNR2B (Fig. 5; Table I). This serine corresponds
to serine 1303 in the full-length NR2B subunit. Analysis of the
time course of appearance of the tryptic phosphopeptide peaks
indicated that phosphorylation of this serine is rapid, whereas
the other major, unidentified phosphopeptides (3 and 4) ap-
peared more slowly and hence probably represent a lower af-
finity phosphorylation site or sites (Fig. 6).
To demonstrate that serine 1303 is phosphorylated in full-
length NR2B, we compared peptide maps of phosphorylated
GST-tNR2B with those from NR2B phosphorylated in the
postsynaptic density fraction by endogenous CaM kinase II and
purified by immunoprecipitation. NR2B labeled in this way
contained two major phosphopeptide peaks that co-migrated
during HPLC with peaks 7 and 8 from GST-tNR2B, demon-
strating that the major site of phosphorylation of NR2B by
CaM kinase II in the PSD fraction is serine 1303 (Fig. 7).
FIG. 9. NR2B is phosphorylated primarily on serine residues
in organotypic cultures. Eight organotypic hippocampal cultures
were prepared and labeled overnight with [32P]PO4, after which the
cells were frozen and homogenized. NR2B was immunoprecipitated
from the homogenate, purified on an SDS-PAGE gel, and hydrolyzed in
acid as described under “Experimental Procedures.” The acid hydroly-
sate was mixed with 2 mg each of standard phosphoserine, phospho-
threonine, and phosphotyrosine and then spotted onto a cellulose thin
layer plate and subjected to electrophoresis as described under “Exper-
imental Procedures.” Left, positions of the standards, detected with a
ninhydrin spray reagent, are indicated by circles. Right, radiolabeled
amino acids visualized by PhosphorImager analysis.
FIG. 10. Serine 1303 in NR2B is phosphorylated in organotypic
hippocampal cultures. Organotypic hippocampal cultures (10 cul-
tures each containing 4 or 5 slices) were labeled with [32P]phosphate for
8 h, frozen, and homogenized. NR2B was immunoprecipitated from the
homogenate, purified by SDS-PAGE, and digested with trypsin as de-
scribed under “Experimental Procedures.” Radiolabeled tryptic pep-
tides generated from NR2B were fractionated on cellulose thin layer
plates by electrophoresis in the first dimension and chromatography in
the second dimension as described under “Experimental Procedures.”
The positive pole is to the left; the negative pole to the right. The
positions of the peptides were visualized by PhosphorImager analysis.
The mobilities of peptides generated from NR2B labeled in vivo were
compared with those of standard purified peptides 5, 7, and 8 prepared
by HPLC purification from phosphorylated GST-tNR2B as described in
the legend to Fig. 7. A, 600 cpm of tryptic digest of NR2B from organo-
typic cultures; B, 200 cpm each of purified peptides 5, 7, and 8; C, 500
cpm of tryptic digest of NR2B plus 130 cpm each of peptides 5, 7, and 8
mixed before application to the cellulose plate.
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Finally, we used two strategies to examine whether serine
1303 is phosphorylated in living neurons. A phosphosite-spe-
cific antiserum was raised against a phosphorylated synthetic
peptide with the amino acid sequence surrounding serine 1303.
We used this antiserum to detect the presence of the phospho-
rylated site in a protein band from brain homogenates with the
mobility of NR2B and NR2A (Fig. 8). Homogenates of hip-
pocampal slices that had been incubated in a calcium-free
buffer showed less antibody binding to this band compared
with homogenates of slices incubated in the phosphatase inhib-
itor okadaic acid. These two conditions decrease and increase
the basal level of activated CaM kinase II, respectively (35).
Therefore, the results are consistent with the hypothesis that
CaM kinase II phosphorylates serine 1303 and/or the cognate
site in NR2A in vivo. Proof of the hypothesis and clarification of
the physiological conditions that regulate phosphorylation will
require additional experiments. We also prepared two-dimen-
sional TLC peptide maps of immunoprecipitated NR2B labeled
with 32P in situ in organotypic cultures. These maps were
compared with those of HPLC-purified phosphopeptide stand-
ards from labeled GST-tNR2B. NR2B labeled in the living
neurons contained spots corresponding to peptides 7 and 8 from
GST-tNR2B (Fig. 10). Taken together, these experiments make
a strong case that serine 1303 is a principal site of phosphoryl-
ation of NR2B in vivo.
Serine 1303 on NR2B is the first identified site of phospho-
rylation of the NMDA type glutamate receptor by CaM kinase
II. The demonstration that this site is phosphorylated in living
hippocampal neurons suggests that its phosphorylation may
regulate receptor channel properties or interactions with other
proteins. Physiological studies have led to the hypothesis that
some of the downstream effects of NMDA receptor activation
are mediated by CaM kinase II. For example, the threshold for
induction of long term potentiation versus long term depression
may be governed by steady state CaM kinase II activity (47,
48). One mechanism by which the threshold could be modified
would be through regulation of the NMDA receptor itself. Iden-
tification of a principal phosphorylation site will facilitate stud-
ies of the functional role of phosphorylation of the NMDA
receptor by CaM kinase II.
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